Pharmaceutical combinations of oxycodone and naloxone

US7943173B2 · kind B2 · utility

Assignee

• PURDUE PHARMA L.P. · US

Inventors

• Christopher Breder · Bethesda, US
• Robert D. Colucci · Newtown, US
• Stephen A. Howard · Flemington, US
• Benjamin Oshlack · Boca Raton, US
• Curtis Wright · Gloucester, US

Key dates

• Filing date: Jul 18, 2002
• Grant date: May 17, 2011
• Expiry date: Jul 18, 2022

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K9/5078
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed in certain embodiments is a pharmaceutical composition comprising from 10 to 40 mg of oxycodone or a pharmaceutically acceptable salt thereof and 0.65 to 0.90 mg naloxone or a pharmaceutically acceptable salt thereof.